← Current compounder rows

Current NDC auxiliary source row compounder:4411

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
83298-100
Product Ndc
83298-100
Product Ndc Digits
83298100
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
Miglustat Oral Suspension
Proprietary Name Suffix
[empty]
Nonproprietary Name
Miglustat Oral Suspension
Dosage Form Name
SUSPENSION
Route Name
ORAL
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
Mark Cuban Cost Plus Manufacturing and Compounding LLC
Establishment Name
Mark Cuban Cost Plus Manufacturing and Compounding LLC
Establishment Fei
[empty]
Substance Name
MIGLUSTAT
Active Ingredients Info
100 mg/150 mL
History Active Ingredients Raw
MIGLUSTAT
History Active Ingredients Info Raw
100 mg/150 mL
History Dosage Raw
SUSPENSION
Dea Schedule
[empty]
Package Ndc Raw
83298-100-30
Package Ndc
83298-100-30
Package Ndc Digits
8329810030
Package Ndc11
83298010030
Package Description
150 mL in 1 BOTTLE (83298-100-30)
Reporting Period Raw
2024-2
Reporting Period
2024-2
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:4411
Source Row Number
4411
Source Row Hash
68e678077aa519466f3a5725d5b16f04ef2411529b98b75e93a73084028119f6
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45

Exact raw FDA source fields#

{
    "ROUTENAME": "ORAL",
    "PRODUCTNDC": "83298-100",
    "DEASCHEDULE": "",
    "LABELERNAME": "Mark Cuban Cost Plus Manufacturing and Compounding LLC",
    "SUBSTANCENAME": "MIGLUSTAT",
    "DOSAGEFORMNAME": "SUSPENSION",
    "NDCPACKAGECODE": "83298-100-30",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Miglustat Oral Suspension",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "Miglustat Oral Suspension",
    "PACKAGEDESCRIPTION": "150 mL in 1 BOTTLE (83298-100-30) ",
    "ACTIVEINGREDIENTSINFO": "100 mg/150 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:4411
Source Row Number
4411
Status Scope
package
Lookup Ndc
83298-100-30
Lookup Ndc Digits
8329810030
Product Ndc
83298-100
Product Ndc Digits
83298100
Package Ndc
83298-100-30
Package Ndc Digits
8329810030
Package Ndc11
83298010030
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2024-2
Reporting Period
2024-2
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
68e678077aa519466f3a5725d5b16f04ef2411529b98b75e93a73084028119f6
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45